BridgeMD
New treatment option for Type 2 Diabetes
Official title Feasibility of Aerobic Exercise With Blood Flow Restriction Training in People Living With Type 2 Diabetes
ClinicalTrials.gov ID: NCT07196371
What this study is testing
- What it's testing
- The goal of this trial is to learn if blood flow restriction training with treadmill walking is possible for individuals living with type 2 diabetes. It will also learn about how the blood flow restriction with treadmill walking could improve health.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 64
You may be able to join if
- Diagnosed with type 2 diabetes (5.7% \< HbA1c \< 9.0%)
- Not regularly physically active (150 mins moderate-vigorous physical activity per week)
You likely can't join if
- Musculoskeletal issues preventing exercise training
- Unstable medications over the last 3 months
- Absolute contraindications to BFR (i.e. peripheral vascular disease)
- A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions
- A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis)
- Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely
See the full eligibility criteria
- Diagnosed with type 2 diabetes (5.7% \< HbA1c \< 9.0%)
- Not regularly physically active (150 mins moderate-vigorous physical activity per week)
- Musculoskeletal issues preventing exercise training
- Unstable medications over the last 3 months
- Absolute contraindications to BFR (i.e. peripheral vascular disease)
- A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions
- A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis)
- Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely
- Currently prescribed any medication which would impact the ability to use a heart rate monitor to accurately track intensity
The study team makes the final eligibility decision.
Where it's taking place
- Okanagan, British Columbia, Canada
- Fredericton, New Brunswick, Canada
- Guelph, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Okanagan, British Columbia, Canada; Fredericton, New Brunswick, Canada; Guelph, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.